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In Issue 5, 2010 of the Cochrane Database of Systematic Reviews the Cochrane Injuries 
Group published its 100th systematic review.  Such a milestone provides a good opportunity 
to reflect on the ways in which the Group’s output may have influenced clinical practice, 
health care policy and research since its inception in 1997.   
Cochrane systematic reviews should be uniquely placed to influence policy, practice and 
research as they provide a comprehensive critical summary of what is known about 
effectiveness on a given topic.  In addition, Cochrane reviews are periodically updated in 
light of new evidence.  Yet, it has long been recognised that the relationship between 
research and policy or practice is a complex one [1]; and that research may not always have 
the impact that researchers desire [2].  One reason for this is that research evidence is only 
one factor in shaping policy and practice.  Decision makers are subject to many different 
influences including political imperatives, the media, non research evidence and powerful 
lobbying groups such as industry [3,4].  However, despite these potential barriers there is 
clear indication that Cochrane Injuries Group (CIG) reviews have had a demonstrable impact 
on policy and practice.  The examples presented here have been generated through an 
impact assessment being undertaken by the author.  This evaluation has focused on specific 
reviews only and there are undoubtedly other examples of impact not included here. 
Injuries Group authors have made a significant contribution to injury prevention with the 
publication of over 30 reviews focused on injury prevention topics.  This is a substantial 
body of work and many of these reviews have contributed to the formulation of guidelines 
and policy at both the national and international level.  For example, WHO reports on the 
prevention of child injury [5] and road traffic injury [6] cite 15 and nine Injuries Group 
reviews respectively.  There are also examples of CIG reviews being used to inform the 
development of international policy. These include: 
 A review of safety education for pedestrians [7] highlighted the lack of evidence to 
support pedestrian education for children as a road safety strategy.  This review was 
cited in reports in the UK, Europe and North America and included in policy 
documents produced by the EU and the WHO.  
 A review of traffic calming [8] was cited in a WHO report on traffic injury prevention 
[6] and fed into recommendations endorsed by member states.   
 Reviews on the use of helmets for the prevention of injuries [9,10] have influenced 
the development of WHO policy on helmet laws [11]; legislation that is now being 
implemented widely in Asia and Africa. 
As well as the prevention of injuries the remit of the Group also includes treatment and 
rehabilitation.  Analysis of the impact of five CIG reviews evaluating strategies for fluid 
resuscitation found evidence that they had influenced practice, policy and research.   
Citation analysis revealed that the reviews had been widely cited, both in the UK and 
internationally, and were included in over 20 guidelines on fluid resuscitation.  Two reviews 
[12,13] were particularly influential.  The first [12] was instrumental in stimulating debate 
about fluid resuscitation and the findings of the latter [13], a review of human albumin for 
fluid resuscitation, led to a 40% reduction in the use of human albumin in the UK [14].   
Another consideration when evaluating the impact of research is whether it has played a 
part in the targeting of future research [15], and indeed CIG reviews have been instrumental 
in shaping the research agenda.  For instance, the authors of the human albumin review [13] 
highlighted the methodological weaknesses of the available studies and concluded that 
further well conducted studies in the area were essential.  Australian researchers 
subsequently conducted a large RCT comparing albumin and crystalloid [16]; a study that 
provided vital evidence on the best strategy for fluid resuscitation of critically ill patients.  In 
addition, CIG reviews have stimulated primary research in trauma care.  A review on 
steroids in head injury [17] instigated a large multicentre RCT [18], and reviews of anti-
fibrinolytic drugs in surgical [19] and trauma patients [20] provided the stimulus for an RCT 
currently in progress (http://www.crash2.lshtm.ac.uk/). 
Finally it is worth considering how the work of the CIG may have contributed to the 
formulation of values and knowledge.  The impact of research may not always be immediate 
or direct but instead is often cumulative or conceptual with ideas from research gradually 
filtering down into policy or practice [21].  Indeed, one of the roles of research may be to 
create debate and influence the policy agenda [3].  Impact at this level is, of course, difficult 
to demonstrate but it is likely that CIG reviews have played a role in changing ideas and 
attitudes and redefining research practices and beliefs.  For example, the output of the CIG 
may have contributed to a shift in the road safety paradigm away from politically safe 
interventions, such as safety education where the onus is on the individual, by highlighting 
the need for more comprehensive population-based environmental and legislative 
strategies.  In addition, the work of the CIG may have impacted upon research thinking, 
practices and beliefs by promoting the use of systematic review methods and emphasising 
the value of using rigorous scientific methods for the evaluation of road safety 
interventions. 
In conclusion, we have reason to believe that CIG reviews are a valuable resource for 
decision makers involved in the prevention, treatment and rehabilitation of injury.  The task 
of the CIG remains the facilitation of evidence-informed policy and practice through the 
production of high-quality reviews relevant to practitioners, policy makers and the research 
community. 
 The CIG welcomes suggestions for new reviews.  You can contact the Group through: 
www.injuries.cochrane.org.  Membership is open to all, and volunteers are invited to work 
with the Group in a variety of roles. 
The full text of all of the CIG’s reviews are published in the Cochrane Database of Systematic 
Reviews (www.thecochranelibrary.com). 
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